Romulus Capital, a seed-stage venture capital firm focused on investing in and building technology businesses, is suporting two artificial intelligence centers affiliated with the University of Cambridge (MA).
The centers are:
– the Leverhulme Centre for the Future of Intelligence (CFI) and
– the Centre for the Study of Existential Risk (CSER) at the University of Cambridge.
CFI, which opened late this year, was launched to explore both the opportunities and the challenges that humans will face as they continue to develop artificial intelligence more prominently and elegantly. A £10 million grant from the Leverhulme Trust allows global thought leaders in computer science, philosophy, and social science to collaborate on their examinations of the ethical questions raised by the development of artificial intelligence.
CSER is a multidisciplinary center dedicated to to the study and mitigation of risks that could lead to human extinction.
Founded out of MIT in 2008, Romulus Capital has made significant investments in companies utilizing artificial intelligence including Ginger.io, which allows mental health professionals to track their patients’ moods and behavior; Humanyze, which uses data and analytics to create productive office environments; and Cogito, which analyzes data embedded in voices and tones to help call centers and other organizations practice empathy.